Shares of Stereotaxis (NYSE:STXS) shot up in morning trading today after the robotic surgery company reported Street-beating Q4 results and predicted double-digit revenue growth this year. The St. Louis–based company, creator of robotic technologies for the treatment of cardiac arrhythmias, reported a loss of –$1.18 million, or –2¢ share, on sales of $6.82 million for the […]
Robotics
Titan Medical brings in another $23 million
Titan Medical (TSX:TMD;OTC:TITFX) today announced the closing of a $23 million bought deal. The Toronto-based surgical robotics company conducted the sale by way of a short form prospectus in each of the provinces of British Columbia, Alberta and Ontario — as well as a private placement in the U.S. Last month, Titan Medical raised an additional […]
Titan Medical dips on Q4 losses
Titan Medical (TSX:TMD;OTC:TITFX) shares took a hit today on fourth-quarter losses that topped -$20 million. The Toronto-based company posted losses of -$20.6 million, for the three months ended Dec. 31, 2020, for a bottom-line slide into the red after posting profits of $2.4 million in the fourth quarter of 2019. Titan Medical attributed the results to […]
12 surgical robotics companies you need to know
Surgical robotics remains a hot area in medtech — even as it faces headwinds from the COVID-19 pandemic. Intuitive Surgical (NSDQ:ISRG) pioneered robotic surgery through the early 2000s and remains the dominant player, but major companies including Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) have big plans to enter the space and compete. Meanwhile, Stryker (NYSE:SYK) has built a […]
BREAKING: TransEnterix announces name change, new category of surgery
TransEnterix (NYSE:TRXC) announced today that it will change its name to Asensus Surgical and introduce a new category of surgery to its offerings. Research Triangle Park, N.C.-based Asensus Surgical said in a news release that its name change represents its broader vision of shaping the future of surgery by integrating computer vision and machine learning with […]
Could artificial intelligence boost surgical robotics to new heights?
Ken Goldberg thinks artificial intelligence will enable surgical robots to achieve their best function — not replacing surgeons but augmenting their work by reducing the monotony of specific subtasks like suturing. The William S. Floyd Jr. Distinguished Chair in Engineering at UC Berkeley, Goldberg and his research team have continued to advance the field. The group — which includes postdoctoral […]
ReWalk Robotics misses on revenues in Q4
ReWalk Robotics (NSDQ:RWLK) shares dipped pre-market today on fourth-quarter results that couldn’t top the consensus forecast. The Marlborough, Mass.-based robotic exoskeleton device maker posted losses of -$2.9 million, or -14¢ per share, on sales of $1.2 million for the three months ended Dec. 31, 2020, for a 17.6% bottom-line gain on sales growth of 3.1%. Adjusted […]
TransEnterix brings in $79.6M from stock offering
TransEnterix (NYSE:TRXC) recently announced that it has closed on a public offering of more than 26.5 million shares of its common stock, with roughly $79.6 million in aggregate gross proceeds for the surgical robotics company. The offering, in combination with recent financing activity, extends TransEnterix’s cash runway into 2024. The money will go toward general corporate […]
DTW Podcast: CEO Johnson on entrepreneurship, upcoming MedtechColor Pitch Contest; Krum handicaps medtech Q4
In this episode of the DeviceTalks Weekly Podcast, Angelique Johnson, CEO of MEMstim, shares her “accidental entrepreneur” story and how it has enabled her the help others pursuing the same dream. Also, Johnson, co-founder of MedtechColor, an organization seeking to further the advancement of people of color in the medical device industry, details the group’s […]
Titan Medical closes on $11.5M offering
Titan Medical (TSX:TMD; NSDQ:TMDI) announced today that it has closed on a previously announced offering, raising $11.5 million in aggregate gross proceeds. The Toronto-based surgical robotics company conducted the sale by way of a short form prospectus in each of the provinces of British Columbia, Alberta and Ontario — as well as a private placement in […]
J&J touts results of robotic bronchoscopy trial
Johnson & Johnson (NYSE:JNJ) subsidiary Auris Health is touting positive results from a study of its Monarch robotic bronchoscopy system. Monarch, a first-of-its-kind robotic technology, was cleared by the FDA in March 2018 for diagnostic and therapeutic bronchoscopies. In May, Auris touted interim results from an independent feasibility study designed to assess the platform. In that study, in 82 procedures, researchers […]
